期刊文献+

一种鉴别粗品肝素钠不同种属来源的简便方法 被引量:3

A Simple Method for Identification of Crude Heparin Sodium from Various Species
下载PDF
导出
摘要 目的采用SAX-HPLC快速鉴别不同种属来源的粗品肝素钠。方法通过肝素酶酶解不同种属来源的粗品肝素钠,以其酶解后的二糖组份为考察对象,通过SAX HPLC法比较二糖的相对组成,鉴定种属来源。同时在猪来源肝素中分别添加不同比例(5%,10%,15%,20%,25%)的牛来源肝素或羊来源肝素,经肝素酶酶解后,通过SAX HPLC法鉴别在猪来源肝素中是否能快速检出不同种属来源的其他肝素。结果对于不同种属来源的粗品肝素钠,它们的二糖组成具有显著差异;若猪来源肝素混入5%羊来源肝素,即可通过其二糖组成判断。结论此法操作简便,成本较低,可用于不同种属来源的粗品肝素钠的定性检测。 Objective To identify the origin of species of crude heparin sodium by SAX-HPLC. Methods With thedigested disaccharide components as the study object which was got through heparinase hydrolysis of crude heparinsodium, SAX-HPLC was used to identify the origin of species by the comparison of disaccharide relative composition.Meanwhile, bovine-or ovine-sourced heparin was added to the porcine crude heparin at different proportions(5 %, 10 %, 15 %, 20 %, 25 %). After the digestion by heparinase, it was confirmed whether heparin fromforeign species could be detected quickly within porcine crude heparin by SAX-HPLC. Results There were significantdifferences on disaccharide composition among crude heparin from different species. If porcine crude heparin wasmixed with 5 % ovine crude heparin, it could be detected by the disaccharide composition. Conclusion This method issimple and low-cost, and can be used for the qualitative determination of crude heparin sodium from different species.
出处 《食品与药品》 CAS 2015年第5期318-323,共6页 Food and Drug
关键词 粗品肝素钠 二糖组成 SAX-HPLC 种属 crude heparin sodium disaccharide composition SAX-HPLC species
  • 相关文献

参考文献9

  • 1姬胜利,桑青,张天民.肝素的来源控制、结构分析以及结构与生物活性关系的研究进展[J].中国药学杂志,2012,47(9):660-663. 被引量:17
  • 2Beni S,Limtiaco J F, Larive C K. Analysis and characterization ofheparin impurities [S]. AnalBioanal Chem, 2011,399 (2) : 527-539.
  • 3Beyer T, Matz M, Brinz D, et al. Composition of OSCS-contaminated heparin occurring in 2008 in batches on the Germanmarket [J]. Eur J Pharm Sci, 2010, 40 (4) : 297-304.
  • 4Houiste C, Auguste C, Macrez C, et al. Quantitative PCR anddisaccharide profiting to characterize the animal origin of low-molecular-weight heparins [J]. Chin Appl Thromb Hemost, 2009,15 (1) : 50-58.
  • 5Auguste C, Dereux S, Martinez C, et al. New developments inquantitative polymerase chain reaction applied to control the qualityof heparins [J]. Anal Bioanal Chem, 2011, 399 (2) : 747-755.
  • 6Skidmore M A, Guimond S E, Dumax-Vorzet A F, et al.Disaccharide compositional analysis of heparin sulfate and heparinpolysaccharides using UV or high-sensitivity fluorescence (BODIPY )detection [J]. NatProtoc, 2010,5 (12) : 1983-1992.
  • 7Eldridge S L, Higgins L A, Dickey B J, et al. Insights into thecapillary electrophoresis separation of heparin disaccharides fromnuclear magnetic resonance, pKa, and electrophoretic mobility.measurements [J]. Anal Chem, 2009, 81 (17) : 7406-7415.
  • 8Hitchock A M, Bowman M J, Staples G O, et al. Improved workup for glycosaminoglycan disaccharide analysis using CE with LIF detection [J]. Electrophoresis, 2008, 29 (22): 4538-4548.
  • 9Korir A K, Limtiaco F K, Gutierrez S M, et al. Ultra performace ion-pair liquid chromatography coupled to electros-pray Time- of-flight mass spectrometry for compositional profilingand quantification of heparin and heparin sulfate [J]. Anal Chem, 2008, 80 (4) .- 1297-1306.

二级参考文献35

  • 1FIORE M M, MACKIE I M. Mechanism of lowmolecularweight heparin reversal by platelet factor 4[J]. Thromb Res,2009, 124(1):149-155.
  • 2SOMSEN G W, TAK Y H, TORAO J S, et al. Determination of oversulfated chondroitin sulfate and dermatan sulfate impurities in heparin by capillary electrophoresis[J].J Chromatogr A, 2009, 216(18):4107-4112.
  • 3BRUSTKERN A M, BUHSE L F, NASR M, et al. Characterization of currently marketed heparin products: reversedphase ionpairing liquid chromatography mass spectrometry of heparin digests[J]. Anal Chem, 2010, 82(23):9865-9870.
  • 4RIVERA V, LEVIEUX A, LEVIEUX D. Characterisation of Agl, the major species-specific contaminant of bovine crude heparin, and its identification as an aprotinin/heparin complex [ J ]. J Pharm Biomed Anal, 2002, 29(3) : 443-458.
  • 5RIVERA V, LEVIEUX A, LEVIEUX D. Immunochemical char- acterisation of species-specific antigens in bovine crude heparin [J]. J Pharm Biomed Anal, 2002,29(3) :431-441.
  • 6LEVIEUX A, RIVERA V, LEVIEUX D. Immunochemical con- trol of the species origin of porcine crude heparin and detection of ovine and caprine materials [ J ]. J Pharm Biomed Anal, 2002, 27(1-2) : 305-313.
  • 7WATTA D K, YORKEA S C, SLIM G C. Comparison of ovine, bovine and porcine mucosal heparins and low molecular weight heparins by disaccharide analyses and 13 C-NMR [ J ]. Carbohydr Polym, 1997, 3(1): 5-11.
  • 8AUGUSTE C, DEREUX S, MARTINEZ C, et al.. New develop- ments in quantitative polymerase chain reaction applied to control the quality of heparins [ J ]. Anal Bioanal Chem, 2011,399 (2) : 747 -755.
  • 9HOUISTE C, AUGUSTE C, MACREZ C, et al.. Quantitative PCR and disaccharide profiling to characterize the animal origin of low- molecular-weight heparins[J]. Clin Appl Thromb Hemost ,2009 , 15 ( 1 ) :50-58.
  • 10HUANG Q, YAO C Y, CHEN B, et al.. Species-specific identifi- cation by inhibitor-controlled PCR of ruminant components con- taminating industrial crude porcine hepari [ J ]. Mol Cell Probes, 2006, 20(3-4): 250-258.

共引文献16

同被引文献9

引证文献3

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部